Smart imaging for precise liver cancer ablation
Part of Cancer, Digestive system clinical trials.
This trial uses a smart computer program that combines ultrasound and MRI images to plan a more precise heat treatment (ablation) for liver cancer. It aims to destroy the tumor completely while sparing healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of primary liver cancer (hepatocellular carcinoma).
- Your ablation treatment must be intended to cure the cancer, not just relieve symptoms.
- You must have complete medical records and imaging (like MRI or ultrasound) from before and after your treatment.
- You must be 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat hepatocellular carcinoma (a type of liver cancer): microwave ablation and laparoscopic hepatectomy (keyhole liver surgery). It may help find which option works better for tumor control and recovery in people with limited, non-spread cancer.
This study uses artificial intelligence to analyze imaging and tumor data from patients with hepatocellular carcinoma (liver cancer) being treated with a combination of TACE (a minimally invasive procedure), immunotherapy, and targeted therapy. The goal is to better predict which patients will respond well to treatment.
This study tests new criteria for evaluating how well thermal ablation (using heat to destroy cancer nodules) worked in people with hepatocellular carcinoma (HCC, a type of liver cancer). It aims to improve follow-up imaging with contrast-enhanced ultrasound (CEUS) or CT/MRI to see if the treatment was successful.
This study follows patients who are having a procedure called thermal ablation to treat liver tumors. It aims to learn more about how well the procedure works and how safe it is.
This trial uses an AI system to help doctors plan surgery for liver cancer. It is for people who have had a CT scan of their liver and may or may not have a liver tumor.
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.